GSK’s Breo Breathing A Little Easier In Asthma, But More Studies Ahead
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA advisory committee votes recommends Breo Ellipta for asthma in adults with post-approval safety study, but panel wants additional premarket efficacy and safety data for adolescents.